000			01353 a2200361 4500
005			20250516183649.0
264		0	_c20140818
008			201408s 0 0 eng d
022			_a1432-2072
024	7		_a10.1007/s00213-013-3364-6 _2doi
040			_aNLM _beng _cNLM
100	1		_aPerkins, Kenneth A
245	0	0	_aAn efficient early phase 2 procedure to screen medications for efficacy in smoking cessation. _h[electronic resource]
260			_bPsychopharmacology _cJan 2014
300			_a1-11 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review
650	0	4	_aAntidepressive Agents, Second-Generation _xtherapeutic use
650	0	4	_aBenzazepines _xtherapeutic use
650	0	4	_aBupropion _xtherapeutic use
650	0	4	_aClinical Trials, Phase II as Topic _xmethods
650	0	4	_aCross-Over Studies
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aFeasibility Studies
650	0	4	_aHumans
650	0	4	_aQuinoxalines _xtherapeutic use
650	0	4	_aResearch Design
650	0	4	_aSmoking Cessation _xmethods
650	0	4	_aValidation Studies as Topic
650	0	4	_aVarenicline
700	1		_aLerman, Caryn
773	0		_tPsychopharmacology _gvol. 231 _gno. 1 _gp. 1-11
856	4	0	_uhttps://doi.org/10.1007/s00213-013-3364-6 _zAvailable from publisher's website
999			_c23328378 _d23328378